These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7954177)

  • 1. Toxic effects of theophylline caused by fluvoxamine.
    van den Brekel AM; Harrington L
    CMAJ; 1994 Nov; 151(9):1289-90. PubMed ID: 7954177
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine-induced theophylline toxicity.
    DeVane CL; Markowitz JS; Hardesty SJ; Mundy S; Gill HS
    Am J Psychiatry; 1997 Sep; 154(9):1317-8. PubMed ID: 9286199
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy.
    Sperber AD
    Drug Saf; 1991; 6(6):460-2. PubMed ID: 1793525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline toxicity induced by tetracycline.
    McCormack JP; Reid SE; Lawson LM
    Clin Pharm; 1990 Jul; 9(7):546-9. PubMed ID: 2376112
    [No Abstract]   [Full Text] [Related]  

  • 5. [Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease].
    Talseth T; Kongerud J; Boye NP; Bredesen JE
    Tidsskr Nor Laegeforen; 1981 Oct; 101(29):1648-50. PubMed ID: 7339948
    [No Abstract]   [Full Text] [Related]  

  • 6. Cimetidine-theophylline interaction: report of four patients.
    Bauman JH; Kimelblatt BJ; Caraccio TR; Silverman HM; Simon GI; Beck GJ
    Ann Allergy; 1982 Feb; 48(2):100-2. PubMed ID: 6121526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of determining theophylline concentration in serum].
    Bonelli J; Dellinger C; Kraus M; Waginger H; Zanic P
    Wien Med Wochenschr; 1986 Dec; 136(23-24):641-6. PubMed ID: 3564492
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased serum theophylline concentrations secondary to oral verapamil.
    Burnakis TG; Seldon M; Czaplicki AD
    Clin Pharm; 1983; 2(5):458-61. PubMed ID: 6627875
    [No Abstract]   [Full Text] [Related]  

  • 9. [Norfloxacin does not raise theophylline concentrations in plasma].
    Tamura G; Satoh K; Ohtsu H; Fujimoto Y; Aizawa T; Sakai K; Mue S; Takishima T
    Arerugi; 1987 May; 36(5):262-7. PubMed ID: 3662833
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possible interaction between theophylline and fluvoxamine].
    Diot P; Jonville AP; Gerard F; Bonnelle M; Autret E; Breteau M; Lemarie E; Lavandier M
    Therapie; 1991; 46(2):170-1. PubMed ID: 1905066
    [No Abstract]   [Full Text] [Related]  

  • 11. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
    Nolte D; Dusik B
    Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
    [No Abstract]   [Full Text] [Related]  

  • 12. Mexiletine-theophylline interaction.
    Stanley R; Comer T; Taylor JL; Saliba D
    Am J Med; 1989 Jun; 86(6 Pt 1):733-4. PubMed ID: 2729333
    [No Abstract]   [Full Text] [Related]  

  • 13. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline-induced stuttering.
    Gérard JM; Delecluse F; Robience Y
    Mov Disord; 1998 Sep; 13(5):847-8. PubMed ID: 9756159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Theophyllin-dosage in adults; blood level determination as therapeutic control].
    Lunde PK; Lange-Nielsen F; Brørs O
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):173-74. PubMed ID: 7385143
    [No Abstract]   [Full Text] [Related]  

  • 16. Theophylline toxicity due to impaired theophylline degradation.
    Jacobs MH; Senior RM
    Am Rev Respir Dis; 1974 Sep; 110(3):342-5. PubMed ID: 4607286
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature.
    Hamdy RC; Micklewright M; Beecham VF; Moore SW
    J Tenn Med Assoc; 1995 Dec; 88(12):463-4. PubMed ID: 8531477
    [No Abstract]   [Full Text] [Related]  

  • 20. A manifestation of theophylline toxicity.
    Williams J; Krish G; Dralle WM
    J Tenn Med Assoc; 1989 Mar; 82(3):127-8. PubMed ID: 2709851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.